Navigation Links
BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer
Date:11/21/2008

ase visit http://www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking Statement

This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the expectations related to the retirement of Dr. Kakkis, the continued clinical development and commercialization of Aldurazyme, Naglazyme, Kuvan, and its product candidates; and actions by regulatory authorities. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: results and timing of current and planned preclinical studies and clinical trials; the content and timing of decisions by the U.S. Food and Drug Administration, the European Commission and other regulatory authorities concerning each of the described products and product candidates; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2007 Annual Report on Form 10-K, and the factors contained in BioMarin's reports on Form 10-Q. Stockholders are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.

BioMarin(R), Naglazyme(R) and Kuvan(R) are registered trademarks of BioMarin Pharmaceutical Inc.

    Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC.

     Contact:
     Investors                                    Media
     
'/>"/>
SOURCE  BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. BioMarin to Present at the BioCentury NewsMakers Conference
3. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
4. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
7. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
8. BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
9. BioMarin to Host First Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, April 29 at 5:00 p.m. ET (23:00 CET)
10. BioMarin to Present at the Morgan Stanley Healthcare Conference
11. BioMarin Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... recipient,s immune system identifies the transplanted organ as foreign ... T cells, the immune cells that mediate rejection, must ... order to migrate to the transplanted organ. In this ... Fadi Lakkis and colleagues at the University of Pittsburgh ... cells is not required for migration. Instead, these cells ...
(Date:5/17/2013)... - Elsevier, a world-leading provider of scientific, technical and ... of a recent study in Reproductive BioMedicine ... that those with an abnormal chromosomal composition can be ... to blastocysts, thereby classifying the risk of genetic abnormality ... group has undertaken a retrospective study, using their predictive ...
(Date:5/17/2013)... TRIANGLE PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability , ... and insect pressures , Syngenta ... opening celebration today at the company’s RTP Innovation Center. ... Lab allows company researchers to simulate any agricultural climate ...
(Date:5/17/2013)... Calif. , May 17, 2013  Cellular ... has achieved 50% enrollment of the total projected ... evaluate the safety and preliminary efficacy of the ... therapy for Knee Osteoarthritis (KOA). To date the ... reported. The Phase I open label ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2
... China , May 25 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, Inc. ... a leading over-the-counter Hepatitis B medicine,Xin Aoxing Oleanolic Acid Capsule ("Xin ... that it has,commenced assembly of its production line for its proprietary ... , ...
... , NEW YORK , May 25 Pfizer Animal ... in aquaculture vaccines, R&D and healthcare diagnostic services.  The acquisition further expands ... cattle, swine, poultry and, now, fish. , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO ) , ...
... 25 Today Organic Miracle, Inc. CEO Jerry Bakke , ... have developed a natural, non-toxic solution to the Gulf oil spill contamination ... , , , ... 701 (Building a Better World Green) is a super concentrated, high efficiency, ...
Cached Biology Technology:Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 2Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 3Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 4Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 2Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 3Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 4Organic Miracle, Inc.'s Product, BBW G701, is a Natural, Non-Toxic Means of Stopping and Reversing the Catastrophic Contamination Caused by the Gulf Oil Spill 2
(Date:5/16/2013)... that are about 23 million years old give ... gobioid order, one of the most species-rich groups ... by paleontologist Professor Bettina Reichenbacher from the Division ... Earth and Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in ... of fish fossils which they assign to the ...
(Date:5/16/2013)... Abwe, a conservationist working in Cameroon and the manager ... just been awarded the prestigious Whitley award. The ... called "The Green Oscars" because it celebrates the extraordinary ... in developing countries. Abwe was selected for the ... preserve Cameroon,s Ebo Forest and its wildlife inhabitants., HRH ...
(Date:5/15/2013)... gout risk, new research reveals that vitamin C, also ... levels to a clinically significant degree in patients with ... with allopurinol, appears to have a weak effect on ... the results published in the American College of Rheumatology ... Gout is an inflammatory arthritis that causes excruciating pain ...
Breaking Biology News(10 mins):Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Vitamin C does not lower uric acid levels in gout patients 2
... Clinicians, researchers and allied health professionals with ... and management, are invited to convene in Singapore ... Meeting from December 10-13, 2010. The ... lectures by key international experts and thought leaders ...
... 2010) Rare but devastating, eye cancer can strike anyone ... leaves half of all patients partially blind. But a ... the University of Colorado School of Medicine, may change all ... the eye can block up to 55 percent of harmful ...
... broken by Michigan State University biochemists helps explain ... could lead to discoveries related to plant tolerance ... brings together two classic problems in plant biology," ... molecular biology. "One is that plants protect themselves ...
Cached Biology News:Clinical management of osteoporosis to be focus of Singapore meeting 2Researcher finds revolutionary way to treat eye cancer 2Researchers discover novel mechanism protecting plants against freezing 2